REG - TempletonEmerg.Mkt. - Result of AGM

Templeton Emerging Markets Investment TrustAnnouncement

10/07/2025 14:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250710:nRSJ6068Qa&default-theme=true

RNS Number : 6068Q  Templeton Emerging Markets IT PLC  10 July 2025

Templeton Emerging Markets Investment Trust PLC

Legal Entity Identifier (LEI): 5493002NMTB70RZBXO96

 

Results of Annual General Meeting

 

The Annual General Meeting of Templeton Emerging Markets Investment Trust PLC
(the "Company") was held at 12noon on 10 July 2025.  The following
resolutions were duly passed on a show of hands.  Resolutions numbered 1 to 7
were passed as ordinary resolutions and resolutions 8 to 10 were passed as
special resolutions.

 

ORDINARY BUSINESS

 

Ordinary Resolutions

 

1.   To receive and adopt the Directors' and Auditor's Reports and Financial
Statements for the year ended 31 March 2025.

 

2.   To approve the Directors' Remuneration Report for the year ended 31
March 2025.

 

3.   To declare a final dividend of 3.25 pence per share for the year ended
31 March 2025.

 

4.   To appoint the Directors:

4.1.      To re-elect Abigail Rotheroe as a Director.

4.2.      To re-elect Charlie Ricketts as a Director.

4.3.      To re-elect David Graham as a Director.

4.4.      To re-elect Magdalene Miller as a Director.

4.5.      To re-elect Angus Macpherson as a Director.

4.6.      To elect Sarika Patel as a Director.

 

5.   To re-appoint Ernst & Young LLP as auditor of the Company, to act
until the conclusion of the next general meeting of the Company at which
audited accounts are laid before the members.

 

6.   To authorise the Directors to determine the auditor's remuneration.

 

SPECIAL BUSINESS

 

Ordinary Resolution

 

7.   That, in substitution for any existing authority, the Directors be
generally and unconditionally authorised to allot equity securities (as
defined in Section 560 of the Companies Act 2006 (the 'Act')) pursuant to
Section 551 of the Act, up to an aggregate nominal amount of £2,542,000
(being an amount equal to 5% of the existing issued share capital of the
Company as at 16 May 2025, being the latest practicable date before the date
of this notice), provided that this authority shall, unless renewed, varied or
revoked by the Company, expire on 30 September 2026 or, if earlier, the
conclusion of the Company's AGM to be held in 2026 save that the Company may,
before such expiry, make offers or agreements which would or might require
equity securities to be allotted and the Directors may allot equity securities
in pursuance of such offer or agreement notwithstanding that the authority
conferred by this resolution has expired.

 

Special Resolutions

 

8.   That, in substitution for any existing authority, subject to the
passing of resolution 7, the Directors be given the general power pursuant to
sections 570 and 573 of the Act to allot equity securities (as defined by
Section 560 of the Act) for cash pursuant to the authority conferred by
resolution 7, and/or to sell equity securities held as treasury shares for
cash pursuant to Section 727 of the Act, in each case as if Section 561(1) of
the Act did not apply to any such allotment or sale, provided that this power
shall be limited to:

(a)  any such allotment and/or sale of equity securities in connection with
an offer or issue by way of rights or other pre-emptive offer or issue, open
for acceptance for a period fixed by the directors, to holders of ordinary
shares (other than the Company) on the register on any record date fixed by
the directors in proportion (as nearly as may be) to the respective number of
ordinary shares deemed to be held by them, subject to such exclusions or other
arrangements as the directors may deem necessary or expedient in relation to
fractional entitlements, legal or practical problems arising in any overseas
territory, the requirements of any regulatory body or stock exchange or any
other matter whatsoever;

(b)  any such allotment and/or sale, otherwise than pursuant to sub paragraph
(a) above, of ordinary shares having an aggregate nominal value, not exceeding
the sum of £2,542,000 (being an amount equal to 5% of the Company's existing
issued share capital, excluding treasury shares, as at 16 May 2025, being the
latest practicable date before the date of this notice); and

(c)  any allotment pursuant to sub-paragraph (b) above being at a price which
is at or above the prevailing NAV per share at the time of issue.

The power granted by this resolution will expire on 30 September 2026 or, if
earlier, at the conclusion of the Company's AGM to be held in 2026 (unless
renewed, varied or revoked by the Company prior to or on such date) save that
the Company may, before such expiry, make offers or agreements which would or
might require equity securities to be allotted or equity securities held as
treasury shares to be sold after such expiry and the Directors may allot
and/or sell equity securities and equity securities held as treasury shares in
pursuance of any such offer or agreement notwithstanding that the power
conferred by this resolution has expired.

 

9.   That in substitution for any existing authority, the Company be and is
hereby authorised in accordance with Section 701 of the Companies Act 2006 to
make market purchases (within the meaning of Section 693(4) of the Companies
Act 2006), of its ordinary shares in issue, provided that:

(i)         the maximum number of ordinary shares hereby authorised to
be purchased shall not exceed 14.99% of the Company's issued ordinary share
capital, excluding treasury shares, at the date of the passing of this
resolution;

(ii)        the minimum price which may be paid for a share shall be
the nominal value of an ordinary share (excluding expenses);

(iii)       the maximum price which may be paid (excluding expenses) for
a share shall not be more than the higher of: (a) an amount equal to 105 per
cent of the average of the closing mid-market price for the ordinary shares
(as derived from the Daily Official List of the London Stock Exchange) for the
five business days immediately preceding the date of purchase; and (b) the
higher of the last independent trade price and the highest current independent
purchase bid price on the trading venue where the purchase is carried out;

(iv)       unless renewed, the authority hereby conferred shall expire
15 months after the date of passing of this resolution or, if earlier, at the
conclusion of the Company's AGM to be held in 2026, save that the Company may,
and prior to such expiry, enter into a contract to purchase shares which will
or may be completed wholly or partly after such expiry; and

(v)        shares will only be purchased at a price which is at a
discount to the prevailing NAV per share at the time of purchase.

 

10. That a general meeting, other than an AGM, may be called on not less than
14 clear days' notice, such authority to expire at the conclusion of the AGM
in 2026.

 

 

Proxy votes received were as follows:

                                                                                         For and Discretion       Against            Withheld
 Resolution                                                                              Votes        %           Votes       %
 1       To receive and adopt the Directors' and Auditors Reports and Financial          634,908,737  99.97%      168,562     0.03%  8,700
         Statements for the year ended 31 March 2025

 2       To approve the Directors' Remuneration Report for the year ended 31 March 2025  633,748,498  99.83%      1,057,742   0.17%  279,759
 3       To declare a dividend of 3.25 pence per share for the year ended 31 March 2025  634,810,427  99.96%      271,909     0.04%  3,663

 4.1     To re-elect Abigail Rotheroe as a Director                                      617,018,439  97.18%      17,898,564  2.82%  168,996

 4.2     To re-elect Charlie Ricketts as a Director                                      634,154,535  99.90%      657,172     0.10%  274,292

 4.3     To re-elect David Graham as a Director                                          634,182,100  99.90%      627,827     0.10%  276,072

 4.4     To re-elect Magdalene Miller as a Director                                      634,136,854  99.88%      778,053     0.12%  171,092

 4.5     To re-elect Angus Macpherson as a Director                                      629,239,793  99.12%      5,560,919   0.88%  285,287

 4.6     To elect Sarika Patel as a Director                                             634,068,347  99.88%      733,001     0.12%  284,651

 5       To re-appoint Ernst & Young LLP as auditors                                     634,688,272  99.95%      313,949     0.05%  83,778

 6       To authorise the directors to fix the remuneration of the auditors for the      634,826,755  99.97%      198,145     0.03%  61,099
         year ending 31 March 2026

 7       To give authority to allot shares                                               634,292,146  99.90%      650,017     0.10%  143,836

 8       To give authority to disapply pre-emption rights                                634,230,586  99.89%      718,768     0.11%  136,645

 9       To authorise the Company to purchase its own shares                             634,141,367  99.86%      857,297     0.14%  87,335

 10      To give authority for general meetings to be held on 14 clear days' notice      633,539,724  99.76%      1,501,194   0.24%  45,081

 

 

For further information please e-mail temitcosec@franklintempleton.com
(mailto:temitcosec@franklintempleton.com) .

 

 

The information contained in this announcement is restricted and is not for
publication, release or distribution in the United States of America, any
member state of the European Economic Area, Canada, Australia, Japan or the
Republic of South Africa.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGPKKBBNBKDDOD